Anisha Naresh Udeshi
About Anisha Naresh Udeshi
Data last updated:
Anisha Naresh Udeshi was a Director at Cipla Pharmaceuticals Limited (2021–2025), Director at Medispray Laboratories Private Limited (2021–2025) and Director at Meditab Specialities Limited (2021–2025), and held 3 more directorships. The companies operate in Pharma and Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cipla Pharmaceuticals Limited U24239MH2019PLC333266 | Director | 01 Jul 2021 | 2019 | ₹2.19 Cr (FY 2025) | Active |
 Medispray Laboratories Private Limited U52311GA1992PTC002801 | Director | 26 Aug 2021 | 1992 | ₹444 Cr (FY 2025) | Active |
| Meditab Specialities Limited U23240MH1996PLC104442 | Director | 23 Aug 2021 | 1996 | ₹40.03 Cr (FY 2025) | Active |
| Goldencross Pharma Limited U24239MH2000PLC123766 | Director | 08 Jun 2020 | 2000 | ₹188 Cr (FY 2025) | Active |
| Cipla Digital Health Limited U72900MH2022PLC377512 | Director | 25 Feb 2022 | 2022 | ₹14.74 Cr (FY 2025) | Active |
 Cipla Pharma And Life Sciences Limited U24239MH2008PLC381559 | Director | 08 Jun 2020 | 2008 | ₹1,598 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anisha Naresh Udeshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anisha Naresh Udeshi
Anisha Naresh Udeshi was first appointed on 08 Jun 2020 as Director at Goldencross Pharma Limited. The most recent appointment on record is 25 Feb 2022 at Cipla Digital Health Limited.
Anisha Naresh Udeshi held 6 earlier board appointments: Cipla Pharmaceuticals Limited (Director, 01 Jul 2021 to 30 Apr 2025); Medispray Laboratories Private Limited (Director, 26 Aug 2021 to 30 Apr 2025); Meditab Specialities Limited (Director, 23 Aug 2021 to 30 Apr 2025); Goldencross Pharma Limited (Director, 08 Jun 2020 to 30 Apr 2025); Cipla Digital Health Limited (Director, 25 Feb 2022 to 30 Apr 2025); and 1 more.